Side-by-side comparison of AI visibility scores, market position, and capabilities
Synopsys (SNPS) reported $6.1B revenue in FY2024, up 15% YoY. World's #1 EDA software company. Critical for AI chip design. ~20,000 employees. HQ: Sunnyvale, CA. Market cap ~$60B.
Synopsys, Inc. is the world's leading provider of electronic design automation (EDA) software and semiconductor IP, headquartered in Sunnyvale, California. Founded in 1986, Synopsys develops the software tools that engineers use to design and verify complex chips — from AI accelerators to smartphone processors. Without EDA software, modern semiconductor design at nanometer scales would be impossible. Synopsys reported revenues of $6.1B in FY2024 (ending October 2024), up 15% year-over-year, with a market capitalization approaching $60B.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.